Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
33.74
-1.66 (-4.69%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Rapport Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -111.48 | -78.31 | -34.79 | -11.62 |
| Depreciation & Amortization | 1.02 | 0.84 | 0.11 | 0.02 |
| Asset Writedown & Restructuring Costs | - | - | - | 5.45 |
| Loss (Gain) From Sale of Investments | -1.4 | -3.21 | -0.08 | - |
| Stock-Based Compensation | 18.86 | 10.24 | 3.53 | 0.61 |
| Other Operating Activities | 2.03 | 8.03 | 1.39 | 0.38 |
| Change in Accounts Payable | 2.22 | -0.35 | 0.86 | 1.58 |
| Change in Other Net Operating Assets | 1.29 | -2.07 | 1.8 | 0.05 |
| Operating Cash Flow | -87.47 | -64.83 | -27.18 | -3.54 |
| Capital Expenditures | -0.62 | -2.41 | -1.64 | -0.31 |
| Sale (Purchase) of Intangibles | - | - | - | -5.45 |
| Investment in Securities | -186.86 | -167.74 | -77.22 | - |
| Investing Cash Flow | -187.47 | -170.14 | -78.86 | -5.76 |
| Total Debt Issued | - | - | - | 8.73 |
| Net Debt Issued (Repaid) | - | - | - | 8.73 |
| Issuance of Common Stock | 270.79 | 157.71 | 0.05 | 0.03 |
| Repurchase of Common Stock | -0 | - | -0 | - |
| Other Financing Activities | - | - | -0.13 | -0.11 |
| Financing Cash Flow | 270.79 | 221.63 | 145.14 | 43.29 |
| Net Cash Flow | -4.16 | -13.34 | 39.1 | 33.99 |
| Free Cash Flow | -88.09 | -67.23 | -28.82 | -3.85 |
| Free Cash Flow Per Share | -2.26 | -3.24 | -19.14 | -4.95 |
| Levered Free Cash Flow | -54.17 | -44.47 | -17.43 | - |
| Unlevered Free Cash Flow | -54.17 | -44.47 | -17.43 | - |
| Change in Working Capital | 3.5 | -2.42 | 2.65 | 1.62 |
Source: S&P Capital IQ. Standard template.
Financial Sources.